In a world rapidly transforming through biotech innovation, one niche area is catching serious investor and research attention — Cell Surface Marker Detection. Whether it’s cancer diagnostics, immune profiling, or regenerative medicine, this market is at the heart of next-gen healthcare. But what’s driving this silent revolution? Let’s dive into the growing demand,...